SFRP5 hepatic expression is associated with non-alcoholic liver disease in morbidly obese women
Journal Title: Annals of Hepatology - Year 2015, Vol 14, Issue 5
Abstract
Background and aims. Secreted frizzled-related protein 5 (SFRP5) was recently described as a new adipokine protective for hepatic steatosis and other obesity-related complications in the mouse model. To date, SFRP5 expression in non-alcoholic fatty liver disease (NAFLD) has not been fully assessed in humans. We measured circulating SFRP5 levels and its expression in liver and adipose tissue, and evaluated its association with NAFLD in morbidly obese women. Material and methods. Fifty-four morbidly obese women undergoing bariatric surgery were included in the study. Liver biopsies were used for histology and hepatic triglyceride content quantification. Circulating SFRP5 levels were measured through enzyme-linked immunoabsorbent assay, and SFRP5 expression was performed in hepatic and adipose tissue (subcutaneous and visceral). Results. Although circulating SFRP5 levels showed a tendency to decrease with NAFLD progression, no significant differences were observed among non-alcoholic steatosis, steatohepatitis, and control subjects. Hepatic SFRP5 expression showed a negative correlation with hepatic triglyceride content (r = -0.349, P = 0.016 for mRNA and r = -0.291, P = 0.040 for SRFP5 protein) and ALT serum levels (r = -0.437, P = 0.001 for SRFP5 protein). In addition, hepatic SFRP5 protein levels were significantly lower in NASH than in control subjects (P = 0.006). Conclusion. This is the first study reporting an association of hepatic SFRP5 expression with NAFLD in humans.
Authors and Affiliations
Roxana Gutiérrez-Vidal, Joel Vega-Badillo, Laura M. Reyes-Fermín, Hugo A. Hernández-Pérez, Fausto Sánchez-Muñoz, Guadalupe S. López-Álvarez, Elena Larrieta-Carrasco, Itzel Fernández-Silva, Nahum Méndez-Sánchez, Armando R. Tovar, Hugo Villamil-Ramírez, Ana M. Mejía-Domínguez, Teresa Villarreal-Molina, Rogelio Hernández-Pando, Francisco Campos-Pérez, Carlos A. Aguilar-Salinas, Samuel Canizales-Quinteros
Keywords
Related Articles
- EP ID EP78492
- DOI -
- Views 99
- Downloads 0
Mice studies disentangle the role of estrogen in gallstone formation
Evidence for liver injury in the setting of obstructive sleep apnea
Introduction. Obstructive sleep apnea (OSA) and non-alcoholic fatty liver disease (NAFLD) are both strongly associated with obesity. Whether OSA is an independent risk factor for liver injury is uncertain. Objective. To...
Acetylcholine receptor antibody positive generalized Myasthenia gravis in association with Primary Biliary Cirrhos
Primary Biliary Cirrhosis and Myasthenia Gravis are both autoimmune conditions, however, there are only rare case reports of their association. This is a case report of acetylcholine receptor antibody positive generalize...
Acute liver failure associated with Garcinia cambogia use
Millions of Americans regularly use herbal supplements, but many are unaware of the potential hidden dangers. Numerous supplements have been associated with hepatotoxicity and, indeed dietary/herbal supplements represent...
Imaging techniques for assessing hepatic fat content in nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD), an emerging clinical entity with worldwide recognition, is today the most common cause of abnormal liver function tests among adults in the United States. In Mexico City, its pre...